eHTA Webinar Series Registration & Pre-webinar Survey – NMIN

Name *

First

Last

Email *

NOTE: You are registering for all three sessions of the series "Using value assessment to inform R&D priorities," on Oct 5, Oct 26 and Nov 23, 2022. All sessions take place on Wednesdays from 11 am - 12 pm PDT (2 - 3 pm EDT). Participation links for each session will be emailed to you in advance.

The sessions build on one another, so if you are unable to attend any individual session, you will be asked to watch the recording of that session before attending the next.

......................................................................................

Pre-webinar survey

We are conducting the following survey to measure the knowledge of eHTA and HTA of people attending our webinars. We would appreciate it if you answered the following questions.

How would you rate your knowledge about early health technology assessment (eHTA)?

High
Medium
Low
None

True or false. Economic evaluation is the analysis of the costs of interventions that may be given to a defined population.

True
False

True or false. Incremental cost-effectiveness is a summary measure of the economic value of a technology compared to the next best current alternative.

True
False

Which of the following is NOT a goal of an eHTA analysis?

To identify physician preferences for new technology
To identify patient preferences for new technology
To determine the feasibility of clinical trials
To estimate the level of effectiveness a technology needs to achieve to be considered cost-effective

Which method is used to estimate the maximum reimbursable price of a technology for a given indication?

Bottom-up market sizing
Headroom analysis
Threshold analysis
None of the above

What are you hoping to learn from this webinar series?